Cheviot Value Management
NVAX icon

Cheviot Value Management’s Novavax NVAX Stock Holding History

Cheviot Value Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$497 Hold
46
– – ﹤0.01% 488
2026
Q2 		$433 Buy
+46
New +$412 ﹤0.01% 407
2025
Q2 		– Sell
-15
Closed -$94 – 453
2025
Q1 		$94 Buy
+15
New +$124 ﹤0.01% 441

Other funds holding NVAX

Shah Capital Management
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
TSP Capital Management Group
TSP Capital Management Group Summit, New Jersey $397M AUM 31.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Cheviot Value Management's NVAX Position: Q3 2026 in Review

Cheviot Value Management held its Novavax (NVAX) position steady in Q3 2026 at 46 shares worth $497. The position accounts for ﹤0.01% of the portfolio, ranked #488.

Cheviot Value Management first reported a position in NVAX in Q1 2025 and has held it in 3 quarters since. 131 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • Cheviot Value Management held 46 shares of Novavax worth $497 as of Q3 2026.
  • Cheviot Value Management left its Novavax share count unchanged in Q3 2026.
  • Novavax made up ﹤0.01% of Cheviot Value Management's portfolio in Q3 2026, its #488 holding.
  • Cheviot Value Management first reported a position in Novavax in Q1 2025 and has held it in 3 quarters since.
  • 131 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on Cheviot Value Management's 13F filing for Q3 2026, filed 9 Nov 2026.